Loading clinical trials...
Loading clinical trials...
Randomized, Double-blind, Placebo-controlled Group, Single Center Study to Evaluate the Effect of 3 Months Policaptil Gel Retard Use on Postprandial Incretin Hormones Release and Satiety in Obese Women Regardless of Macronutrients Intake as Well as Body Mass Changes.
Conditions
Interventions
Libramed
Placebo
Locations
1
Poland
Metabolic Management Center "LINIA"
Katowice, Poland
Start Date
June 29, 2015
Primary Completion Date
February 22, 2019
Completion Date
February 22, 2019
Last Updated
May 30, 2019
NCT06277232
NCT07395973
NCT05301413
NCT05796141
NCT06487832
NCT06076187
Lead Sponsor
Aboca Spa Societa' Agricola
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions